SCHEMBL7705830

SCHEMBL7705830

FC(F)(F)c1c[c]c(-c2cccc(Cl)c2)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GLA P06280 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CNR1 P21554 1/20 0.35
TRPA1 O75762 3/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11287914 0.86 NOTUM (0.43) NOTUM
SCHEMBL7705238 0.82 KIF11 (0.44) ALDH1A1KDM4ESMN1; SMN2CNR1
SCHEMBL7699906 0.80 AHR (0.39) KDM4ELMNAMAPTKMT2ACYP1A2
SCHEMBL7707666 0.78 PTPN5 (0.43)
SCHEMBL17024091 0.76 AHR (0.31)
SCHEMBL7704880 0.74 KDM4E (0.33) GAAALDH1A1KDM4ELMNAHTT
SCHEMBL19002930 0.74
SCHEMBL7702031 0.73 AR (0.41) GAAHPGDALDH1A1GLAMAPT
SCHEMBL7701994 0.73 CYP11B1 (0.36) KDM4ENOTUM
SCHEMBL7702101 0.72 TOP1 (0.35) GAAMEN1KMT2APDK2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed